BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28286044)

  • 1. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer.
    Lim JH; Park JS; Yoon DS
    HPB (Oxford); 2017 May; 19(5):388-395. PubMed ID: 28286044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 300 consecutive cases of pancreatic adenocarcinoma in a single-center in China.
    Lin H; Ma Y; Wang JZ; Pan HY; Liu LX; Qiao HQ; Sun B; Jiang HC
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):189-97. PubMed ID: 27020636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer.
    Abe T; Ohuchida K; Endo S; Ookubo F; Mori Y; Nakata K; Miyasaka Y; Manabe T; Ohtsuka T; Nagai E; Oda Y; Nakamura M
    Surgery; 2017 Apr; 161(4):951-958. PubMed ID: 27939334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
    Lim JE; Chien MW; Earle CC
    Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.
    Papavasiliou P; Hoffman JP; Cohen SJ; Meyer JE; Watson JC; Chun YS
    HPB (Oxford); 2014 Jan; 16(1):34-9. PubMed ID: 23458131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis.
    Asaoka T; Miyamoto A; Maeda S; Hama N; Tsujie M; Ikeda M; Sekimoto M; Nakamori S
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):75-80. PubMed ID: 29428109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
    Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
    HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.
    Kagedan DJ; Raju RS; Dixon ME; Shin E; Li Q; Liu N; Elmi M; El-Sedfy A; Paszat L; Kiss A; Earle CC; Mittmann N; Coburn NG
    HPB (Oxford); 2016 Apr; 18(4):339-47. PubMed ID: 27037203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.